Join Us
Videos Music News Events About Klaudt Family
0 votes
TitleRequired A00-240 Exam

Candidates who bring home this credential will have earned a passing score on the SAS Statistical Business Analysis Using SAS 9: Regression and Modeling exam. This exam is given by SAS and Pearson VUE.

60 scored multiple-choice and short-answer questions (must achieve score of 68% correct to give)

In addition to the 60 scored items, there might be approximately 5 unscored items.

2 hours to finish exam

Use exam ID A00-240; required when registering with Pearson VUE.


AS Certified Statistical Business Analyst Using SAS 9: Regression and Modeling Credential

Created for SAS experts who use SAS/STAT software to conduct and interpret complex statistical data analysis

Successful candidates must have experience in

analysis of variance

linear and logistic regression

preparing inputs for predictive models

measuring model performance.

The SAS Certified Clinical Trials Programmer Using SAS 9 credential is globally renowned for validating SAS Clinical Trials Programmer knowledge. With the SAS Certified Clinical Trials Programmer Certification credential, you stand out in a crowd and prove that you've the SAS Clinical Trials Programmer knowledge compare unique car features in your organization. The SAS Certified Clinical Trials Programmer Using SAS 9 Certification (A00-280) exam will test the candidate's knowledge on following areas. questions for A00-240 exam are written towards the highest standards of technical accuracy, given by our certified material experts and published authors for development. We ensure the top quality and accuracy of our own products. Hopefully you pass the exams successfully with your practice exams. With this SAS Institute A00-240 Practice Exams , you will pass your exam easily at the first attempt. You can also enjoy One year free update to your product.

To get more information about sas statistics certification Questions browse our website: look at more info

Order by: 
Per page: 
  • There are no comments yet